These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 23123577

  • 61. Something old, something new and something very old: drugs for treating type 2 diabetes.
    Kaiser D, Oetjen E.
    Br J Pharmacol; 2014 Jun; 171(12):2940-50. PubMed ID: 24641580
    [Abstract] [Full Text] [Related]

  • 62. Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
    von Herrath MG, Korsgren O, Atkinson MA.
    Clin Exp Immunol; 2016 Jan; 183(1):1-7. PubMed ID: 25989477
    [Abstract] [Full Text] [Related]

  • 63. Brittle type 1 diabetes mellitus.
    Bertuzzi F, Verzaro R, Provenzano V, Ricordi C.
    Curr Med Chem; 2007 Jan; 14(16):1739-44. PubMed ID: 17627511
    [Abstract] [Full Text] [Related]

  • 64. Immunotherapy-based strategies for the treatment of autoimmune diabetes: searching for the cure.
    Phillips BE, Trucco M.
    Curr Pharm Des; 2011 Jan; 17(29):3217-23. PubMed ID: 21864264
    [Abstract] [Full Text] [Related]

  • 65. Replacing insulin with immunotherapy: Time for a paradigm change in Type 1 diabetes.
    Tatovic D, Dayan CM.
    Diabet Med; 2021 Dec; 38(12):e14696. PubMed ID: 34555209
    [Abstract] [Full Text] [Related]

  • 66. Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route.
    Ludvigsson J.
    Int J Mol Sci; 2020 Feb 26; 21(5):. PubMed ID: 32111075
    [Abstract] [Full Text] [Related]

  • 67. Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD)--a study protocol for a pilot randomized controlled trial.
    Lascar N, Kennedy A, Jackson N, Daley A, Dowswell G, Thompson D, Stokes K, Greenfield S, Holder R, Andrews R, Narendran P.
    Trials; 2013 Jun 18; 14():180. PubMed ID: 23777480
    [Abstract] [Full Text] [Related]

  • 68. Revisiting multiple models of progression of β-cell loss of function in type 1 diabetes: Significance for prevention and cure.
    Li X, Cheng J, Zhou Z.
    J Diabetes; 2016 Jul 18; 8(4):460-9. PubMed ID: 26754489
    [Abstract] [Full Text] [Related]

  • 69. The gut microbiota and Type 1 Diabetes.
    Gülden E, Wong FS, Wen L.
    Clin Immunol; 2015 Aug 18; 159(2):143-53. PubMed ID: 26051037
    [Abstract] [Full Text] [Related]

  • 70. Trials in type 1 diabetes: Antigen-specific therapies.
    Coppieters KT, Harrison LC, von Herrath MG.
    Clin Immunol; 2013 Dec 18; 149(3):345-55. PubMed ID: 23490422
    [Abstract] [Full Text] [Related]

  • 71. Vitamin D and diabetes mellitus.
    Harinarayan CV.
    Hormones (Athens); 2014 Dec 18; 13(2):163-81. PubMed ID: 24776618
    [Abstract] [Full Text] [Related]

  • 72. Antigen-Specific Peptide Immunotherapy for Type 1 Diabetes: Proof of Safety, Hope for Efficacy.
    Coppieters K, von Herrath M.
    Cell Metab; 2017 Oct 03; 26(4):595-597. PubMed ID: 28978425
    [Abstract] [Full Text] [Related]

  • 73. Is it time to challenge the established theories surrounding type 1 diabetes?
    Ludvigsson J.
    Acta Paediatr; 2014 Feb 03; 103(2):120-3. PubMed ID: 24344989
    [Abstract] [Full Text] [Related]

  • 74. Diabetes area patent participation analysis - part II: years 2011-2016.
    Boehm M, Crawford M, Moscovitz JE, Carpino PA.
    Expert Opin Ther Pat; 2018 Feb 03; 28(2):111-122. PubMed ID: 29140125
    [Abstract] [Full Text] [Related]

  • 75. Treatment of Diabetes Mellitus Using iPS Cells and Spice Polyphenols.
    Ge Q, Chen L, Chen K.
    J Diabetes Res; 2017 Feb 03; 2017():5837804. PubMed ID: 28758131
    [Abstract] [Full Text] [Related]

  • 76. What goes around, comes around.
    Williams G.
    Lancet; 2012 Jun 16; 379(9833):2235-6. PubMed ID: 22715508
    [No Abstract] [Full Text] [Related]

  • 77. Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease.
    Ziegler AG, Bonifacio E, Powers AC, Todd JA, Harrison LC, Atkinson MA.
    Diabetes; 2016 Nov 16; 65(11):3233-3239. PubMed ID: 27959859
    [Abstract] [Full Text] [Related]

  • 78. State of safety.
    Tsai A.
    Diabetes Forecast; 2015 Nov 16; 68(4):60-2, 65. PubMed ID: 26373221
    [No Abstract] [Full Text] [Related]

  • 79. Immune interventions to preserve β cell function in type 1 diabetes.
    Ehlers MR.
    J Investig Med; 2016 Jan 16; 64(1):7-13. PubMed ID: 26225763
    [Abstract] [Full Text] [Related]

  • 80. Combined Etanercept, GAD-alum and vitamin D treatment: an open pilot trial to preserve beta cell function in recent onset type 1 diabetes.
    Ludvigsson J, Routray I, Vigård T, Hanås R, Rathsman B, Carlsson A, Särnblad S, Albin AK, Arvidsson CG, Samuelsson U, Casas R.
    Diabetes Metab Res Rev; 2021 Oct 16; 37(7):e3440. PubMed ID: 33486892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.